Hugel Bilan de santé

Santé financière contrôle des critères 6/6

Hugel possède un total de capitaux propres de ₩813.3B et une dette totale de ₩24.0B, ce qui porte son ratio d'endettement à 2.9%. Son actif total et son passif total sont ₩899.4B et de ₩86.1B. L'EBIT de Hugel est ₩137.6B ce qui fait que son ratio de couverture des intérêts -9.9. Elle dispose de liquidités et de placements à court terme de ₩412.4B.

Informations clés

2.9%

Ratio d'endettement

₩23.96b

Dette

Ratio de couverture des intérêts	-9.9x
Argent liquide	₩412.43b
Fonds propres	₩813.26b
Total du passif	₩86.15b
Total des actifs	₩899.41b

Mises à jour récentes de la santé financière

Recent updates

Hugel (KOSDAQ:145020) Has A Rock Solid Balance Sheet

Oct 19

An Intrinsic Calculation For Hugel, Inc. (KOSDAQ:145020) Suggests It's 39% Undervalued

Sep 13

There's Reason For Concern Over Hugel, Inc.'s (KOSDAQ:145020) Price

Aug 09

Estimating The Intrinsic Value Of Hugel, Inc. (KOSDAQ:145020)

Jun 10

Hugel (KOSDAQ:145020) Seems To Use Debt Rather Sparingly

Apr 19

Hugel's (KOSDAQ:145020) Performance Is Even Better Than Its Earnings Suggest

Mar 29

Hugel, Inc.'s (KOSDAQ:145020) 25% Price Boost Is Out Of Tune With Earnings

Mar 05

Calculating The Fair Value Of Hugel, Inc. (KOSDAQ:145020)

Mar 04

Are Hugel, Inc.'s (KOSDAQ:145020) Mixed Financials Driving The Negative Sentiment?

Mar 19

What Is The Ownership Structure Like For Hugel, Inc. (KOSDAQ:145020)?

Feb 25

Does Hugel (KOSDAQ:145020) Have A Healthy Balance Sheet?

Feb 04

The Hugel (KOSDAQ:145020) Share Price Has Gained 197%, So Why Not Pay It Some Attention?

Jan 17

Does Hugel's (KOSDAQ:145020) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 29

Does This Valuation Of Hugel, Inc. (KOSDAQ:145020) Imply Investors Are Overpaying?

Dec 14

How Many Hugel, Inc. (KOSDAQ:145020) Shares Do Institutions Own?

Nov 24

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de A145020 ( ₩503.5B ) dépassent ses passifs à court terme ( ₩46.9B ).

Passif à long terme: Les actifs à court terme de A145020 ( ₩503.5B ) dépassent ses passifs à long terme ( ₩39.3B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: A145020 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de A145020 a été réduit de 11.1% à 2.9% au cours des 5 dernières années.

Couverture de la dette: La dette de A145020 est bien couverte par le flux de trésorerie opérationnel ( 491% ).

Couverture des intérêts: A145020 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.

Hugel Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

Hugel (KOSDAQ:145020) Has A Rock Solid Balance Sheet

Hugel (KOSDAQ:145020) Seems To Use Debt Rather Sparingly

Does Hugel (KOSDAQ:145020) Have A Healthy Balance Sheet?

Recent updates

Price target increased by 7.3% to ₩352,545

Investor sentiment improves as stock rises 17%

Hugel, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Hugel (KOSDAQ:145020) Has A Rock Solid Balance Sheet

Investor sentiment improves as stock rises 16%

An Intrinsic Calculation For Hugel, Inc. (KOSDAQ:145020) Suggests It's 39% Undervalued

Consensus EPS estimates increase by 13%

Price target increased by 7.2% to ₩279,444

There's Reason For Concern Over Hugel, Inc.'s (KOSDAQ:145020) Price

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued

Hugel, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Price target increased by 13% to ₩254,889

Investor sentiment improves as stock rises 21%

Estimating The Intrinsic Value Of Hugel, Inc. (KOSDAQ:145020)

Now 21% undervalued

Now 22% undervalued

Hugel, Inc. to Report Q1, 2024 Final Results on May 09, 2024

Hugel (KOSDAQ:145020) Seems To Use Debt Rather Sparingly

Hugel's (KOSDAQ:145020) Performance Is Even Better Than Its Earnings Suggest

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Now 23% undervalued

Hugel, Inc.'s (KOSDAQ:145020) 25% Price Boost Is Out Of Tune With Earnings

Calculating The Fair Value Of Hugel, Inc. (KOSDAQ:145020)

Investor sentiment improves as stock rises 19%

Price target increased by 8.7% to ₩201,750

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Consensus EPS estimates increase by 38%

Price target increased by 8.1% to ₩172,571

Hugel Resubmits BLA for Its Botulinum Toxin, Letybo to the U.S. Fda

Price target decreased by 8.8% to ₩159,250

Hugel, Inc. (KOSDAQ:A145020) acquired additional 3.13% stake in Across Co., Ltd for KRW 9.385 billion.

Investor sentiment deteriorates as stock falls 18%

Price target increased by 7.3% to ₩189,714

Investor sentiment deteriorates as stock falls 18%

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Now 29% undervalued

Now 20% undervalued

Investor sentiment improved over the past week

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

Less than half of directors are independent

Consensus forecasts updated

Investor sentiment improved over the past week

Price target decreased to ₩194,875

Hugel, Inc. Appoints Brent Saunders to its Board of Director

No independent directors

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Price target decreased to ₩214,889

Investor sentiment deteriorated over the past week

Price target decreased to ₩238,333

Consensus EPS estimates fall by 10%

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Are Hugel, Inc.'s (KOSDAQ:145020) Mixed Financials Driving The Negative Sentiment?

What Is The Ownership Structure Like For Hugel, Inc. (KOSDAQ:145020)?

New 90-day low: ₩174,400

Hugel, Inc. Announces Approval to Launch of Letybo 50U in Prc Market

Hugel, Inc., Annual General Meeting, Mar 26, 2021

Does Hugel (KOSDAQ:145020) Have A Healthy Balance Sheet?

Hugel, Inc. to Report Fiscal Year 2020 Results on Feb 09, 2021

Investor sentiment improved over the past week

New 90-day high: ₩224,700

The Hugel (KOSDAQ:145020) Share Price Has Gained 197%, So Why Not Pay It Some Attention?

Price target raised to ₩251,818

Does Hugel's (KOSDAQ:145020) Statutory Profit Adequately Reflect Its Underlying Profit?

Does This Valuation Of Hugel, Inc. (KOSDAQ:145020) Imply Investors Are Overpaying?

New 90-day low: ₩175,600

How Many Hugel, Inc. (KOSDAQ:145020) Shares Do Institutions Own?

Price target raised to ₩241,515

Price target raised to ₩227,788

Price target raised to ₩211,861